Yuina Ueda-Akagi

Acute development of EBV+ T-cell lymphoproliferative disorder after treatment with rituximab for follicular lymphoma.

The sequential occurrence of two or more types of lymphomas is rare, particularly when they involve different cell lineages. We herein report a rare case of the sequential development of T-cell lymphoproliferative disorder (LPD) after treatment with rituximab for follicular lymphoma (FL). Although the efficacy and safe...